The agency concluded that GLP-1 receptor agonists carry a potential increased risk of the rare optic neuropathy and is adding it to the Warnings and Precautions section of every product's label.
|Poll|December 15, 2020
Poll Results: How much more online CE have you taken due to COVID-19?
Author(s)Brooke Henson, Editor
See our latest poll results
Advertisement
Optometry Times® polled our audience with the following question from November 30, 2020 to December 11, 2020:
The poll appeared on
53 ODs responded, in total. Of these:
• 1 reported 0 hours
• 3 reported 1-5 hours
• 9 reported 5-15 hours
• 40 reported more than 15 hours
Advertisement
Related to this article
More consumers spent $100 to $199 on eyewear in Q3 2026, and managed vision care coverage reached a 5-quarter high of 72%.
As artificial intelligence advances, so do VR devices.
A wet AMD biosimilar approval leads this week’s recap, plus Medicare pay updates and tips to avoid burnout and losing patients.
MyoSpectrumNet pulls 3 public fundus datasets into 1 multi-output framework. Screening and grading accuracy held up against dedicated models.
ODs face a $32.63 Medicare conversion factor in 2027, plus 80% payment for the lower-cost service when an E/M visit and 0-day procedure share a date.
Luma, an eye-tracking and assessment tool, helps eye care professionals gain objective insights into visual performance.
Christopher Browning, OD, and Nicholas Garn, OD, now offer cataract surgery and refractive lens exchange in their own practices.
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
2027 Medicare fee schedule trims same-day E/M, 0-day procedure pay
2
Virtual reality perimetry in the management of glaucoma
3
Consumer eyewear spending holds steady in Vision Council Q3 report
4
Takeaways from this week in optometry: November 2-6
5